Rituximab: effective treatment for severe steroid-dependent minimal change nephrotic syndrome?
Hofstra
Julia M
JM
Deegens
Jeroen K J
JK
Wetzels
Jack F M
JF
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D004359:Drug Therapy, Combination; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D009402:Nephrosis, Lipoid / Q000188:drug therapy*; D011241:Prednisone / Q000627:therapeutic use; D019233:Retreatment; D000069283:Rituximab; D013256:Steroids / Q000627:therapeutic use*; D017211:Treatment Failure; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D005938:Glucocorticoids; D007155:Immunologic Factors; D013256:Steroids; D000069283:Rituximab; D011241:Prednisone